申请人:Eli Lilly and Company
公开号:US04835168A1
公开(公告)日:1989-05-30
Compounds of formula (I) ##STR1## wherein R.sup.1 is hydrogen, and R.sup.2 is cyano or --C(.dbd.S)--NH--R.sup.3 ; or R.sup.1 and R.sup.2 taken together are .dbd.C(NH.sub.2).sub.2 or .dbd.C(R.sup.5)(NHR.sup.3 '); R.sup.3 and R.sup.3 ' are hydrogen or --COOR.sup.4 ; R.sup.4 is C.sub.1 -C.sub.10 alkyl, substituted C.sub.1 -C.sub.10 alkyl, C.sub.2 -C.sub.10 alkenyl, substituted C.sub.2 -C.sub.10 alkenyl, phenyl, or substituted phenyl; and R.sup.5 is hydrogen or --S--R.sup.6 where R.sup.6 is C.sub.1 -C.sub.4 alkyl, cyano-C.sub.1 -C.sub.4 alkyl or pyridyl-C.sub.1 -C.sub.4 alkyl, and salts thereof, are useful antiviral agents.
式(I)的化合物##STR1##其中R.sup.1是氢,R.sup.2是氰基或--C(.dbd.S)--NH--R.sup.3;或者R.sup.1和R.sup.2一起是.dbd.C(NH.sub.2).sub.2或.dbd.C(R.sup.5)(NHR.sup.3');R.sup.3和R.sup.3'是氢或--COOR.sup.4;R.sup.4是C.sub.1-C.sub.10烷基,取代的C.sub.1-C.sub.10烷基,C.sub.2-C.sub.10烯基,取代的C.sub.2-C.sub.10烯基,苯基,或取代的苯基;R.sup.5是氢或--S--R.sup.6,其中R.sup.6是C.sub.1-C.sub.4烷基,氰基-C.sub.1-C.sub.4烷基或吡啶基-C.sub.1-C.sub.4烷基,以及其盐,是有用的抗病毒剂。